| Ytd | -70.37% | |
| 1y | -71.84% |
| Open | 0.41 | Prev Close | 0.40 | Low | 0.40 | High | 0.41 | Mkt Cap | 5.89M |
| Vol | 540.37K | Avg Vol | 7.54M | EPS | -1.45 | P/E | N/A | Forward P/E | -0.56 |
| Beta | 1.85 | Short Ratio | 1.06 | Inst. Own | 2.63% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 0.54 | 200-d Avg | 1.19 | 1yr Est | 22.50 |
SNGX News
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 26, 2026) - Investorideas.co
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company fo
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/
Tetra Technologies Inc. (NYSE: TTI) shares fell 15.06% in pre-market trading after announcing a $100
U.S. stocks traded mixed, Nasdaq down 0.3%. Dow up 0.59%, S&P 500 down 0.09%. Consumer discretio
US stocks mixed, Dow up 300 pts. Dow up 0.64%, NASDAQ down 0.34%. Consumer discretionary up 1.7%, en
Semtech Corp (SMTC) reported strong Q1 financial results, beating analysts' estimates. Shares ro
Soligenix shares surged 72.32% in after-hours trading following rapid Bundibugyo virus vaccine devel
https://www.cdc.gov/ebola/situation-summary/index.html
Soligenix (NASDAQ:SNGX) reported quarterly losses of $(0.28) per share which met the analyst consens
US stocks down, NASDAQ falls over 1% on Tuesday. Dow up 0.20%, NASDAQ down 1.24%, S&P 500 down 0
Soligenix ends Phase 3 FLASH2 study for HyBryte. CEO cites unanticipated results. See how this impac
US stocks mixed with Dow up 150 pts. Dow up 0.27%, NASDAQ down 1.06%, S&P 500 down 0.52%. Energy
Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company foc
HyBryte™ demonstrates more rapid and robust treatment response compared toValchlor® during 12-week t
Soligenix (NASDAQ:SNGX) reported quarterly losses of $(0.29) per share which beat the analyst consen
Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company foc
Expert Opinion on Investigational Drugs is an international monthly peer-reviewed journal, evaluatin
https://s27.q4cdn.com/906368049/files/News/2026/Zacks_SCR_Research_03122026_SNGX_Bautz.pdf
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday&#
Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday'
Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling brea
